Cell BioEngines, Inc. is strengthening its Intellectual Property portfolio with a patent licensed from the Icahn School of Medicine at Mount Sinai, in New ...
The companies will collaborate to apply ShapeTX’s AAVid™ capsid discovery platform and transgene engineering technology along with Otsuka&...
NRX-101 demonstrated potent antibacterial effect against antibiotic-resistant pathogens in culture medium and in an artificial urine model D-cycloserine...
The principal investigator, Jennifer Ellis, PhD, Associate Professor of Psychiatry and Behavioral Sciences, JHU School of Medicine will be supported by co-...
Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”) announced a change of the Company’s name to Elutia Inc. The rebranding reflects the ...
IVIS® Spectrum 2 and IVIS SpectrumCT 2imaging systems — new flagship platforms setting the standard in high-throughput performance and versat...
FitoRoot, a biostimulant product composed of three Bacillus strains, is designed to help crops better absorb water, nutrients and strengthen their defenses...
SpendEdge, a global leader in procurement market intelligence space recently connected with a large Europe-based pharma company focused on large and small ...
Designations for Daiichi Sankyo and AstraZeneca's ENHERTU include patients with HER2 expressing metastatic solid tumors and HER2 positive metastatic colo...
“Ono has a strong and proven track record in developing antibody candidates in areas of need, including the development of the anti-PD-1 antibody Opd...
510(k) clearance will allow 23andMe to report an additional 41 genetic variants in the BRCA1 and BRCA2 genes that increase risk for breast, ovarian, prosta...
Depression affects nearly 300 million individuals worldwide and does not have a universally effective treatment. The US economic burden as a result of depr...
To help protect access to medicines for cancer and rare disease patients, AstraZeneca has filed a legal challenge to critical aspects of the drug pri...
Biobot Analytics, a global leader in wastewater intelligence, announced today that it is launching a Respiratory Illnesses Panel that will include concurre...
© 2025 Biopharma Boardroom. All Rights Reserved.
